Skip to main content
Top
Published in: Journal of Nuclear Cardiology 2/2021

01-04-2021 | Angiography | WHAT IS THIS IMAGE?

What is this image? 2021: Image 5 result

Progression of myocardial ischemia to scar on serial 99mTc-sestamibi myocardial perfusion imaging

Authors: Vedran Oruc, MD, Ayman A. Farag, MD, Fadi G. Hage, MD

Published in: Journal of Nuclear Cardiology | Issue 2/2021

Login to get access

Excerpt

Myocardial perfusion imaging with 99mTc-sestamibi is a common, non-invasive method of determining the presence and extent of myocardial perfusion abnormalities in patients with or suspected of having ischemic heart disease. Decreased myocardial uptake of a radionucleotide tracer with exertion is an early finding in the ischemic cascade of obstructive coronary artery disease. As the disease progresses, myocardial perfusion imaging abnormalities may become evident at rest as well as with exertion. Perfusion abnormalities seen on stress images that correct on rest-imaging are often referred to as “ischemia” while rest-imaging perfusion deficits are typically referred to as “scar”. This characterization is simplistic since perfusion abnormalities may occur at rest even in areas with viable non-scarred myocardium and ischemia is often absent with vasodilator stress. Nevertheless, this dichotomization serves a clinical purpose by identifying myocardial regions that likely experience myocardial ischemia during real-life stress and would benefit from revascularization. Though stress images may be used to visualize the total myocardial perfusion abnormality, rest imaging is needed to differentiate between ischemia and scar. …
Literature
1.
go back to reference Hage FG, Ghimire G, Lester D, McKay J, Bleich S, El-Hajj S, Iskandrian AE (2015) The prognostic value of regadenoson myocardial perfusion imaging. J Nucl Cardiol 22:1214-21CrossRef Hage FG, Ghimire G, Lester D, McKay J, Bleich S, El-Hajj S, Iskandrian AE (2015) The prognostic value of regadenoson myocardial perfusion imaging. J Nucl Cardiol 22:1214-21CrossRef
2.
go back to reference Hachamovitch R, Hayes SW, Friedman JD, Cohen I, Berman DS (2003) Comparison of the short-term survival benefit associated with revascularization compared with medical therapy in patients with no prior coronary artery disease undergoing stress myocardial perfusion single photon emission computed tomography. Circulation 107:2900-07CrossRef Hachamovitch R, Hayes SW, Friedman JD, Cohen I, Berman DS (2003) Comparison of the short-term survival benefit associated with revascularization compared with medical therapy in patients with no prior coronary artery disease undergoing stress myocardial perfusion single photon emission computed tomography. Circulation 107:2900-07CrossRef
3.
go back to reference Hage FG, Venkataraman R, Aljaroudi W, Bravo PE, McLarry J, Faulkner M et al (2010) The impact of viability assessment using myocardial perfusion imaging on patient management and outcome. J Nucl Cardiol 17:378-89CrossRef Hage FG, Venkataraman R, Aljaroudi W, Bravo PE, McLarry J, Faulkner M et al (2010) The impact of viability assessment using myocardial perfusion imaging on patient management and outcome. J Nucl Cardiol 17:378-89CrossRef
4.
go back to reference Iskandrian AE, Hage FG, Shaw LJ, Mahmarian JJ, Berman DS (2014) Serial myocardial perfusion imaging: Defining a significant change and targeting management decisions. JACC Cardiovasc Imaging 7:79-6CrossRef Iskandrian AE, Hage FG, Shaw LJ, Mahmarian JJ, Berman DS (2014) Serial myocardial perfusion imaging: Defining a significant change and targeting management decisions. JACC Cardiovasc Imaging 7:79-6CrossRef
5.
go back to reference El-Hajj S, AlJaroudi WA, Farag A, Bleich S, Manaoragada P, Iskandrian AE, Hage FG (2016) Effect of changes in perfusion defect size during serial regadenoson myocardial perfusion imaging on cardiovascular outcomes in high-risk patients. J Nucl Cardiol 23:101-12CrossRef El-Hajj S, AlJaroudi WA, Farag A, Bleich S, Manaoragada P, Iskandrian AE, Hage FG (2016) Effect of changes in perfusion defect size during serial regadenoson myocardial perfusion imaging on cardiovascular outcomes in high-risk patients. J Nucl Cardiol 23:101-12CrossRef
Metadata
Title
What is this image? 2021: Image 5 result
Progression of myocardial ischemia to scar on serial 99mTc-sestamibi myocardial perfusion imaging
Authors
Vedran Oruc, MD
Ayman A. Farag, MD
Fadi G. Hage, MD
Publication date
01-04-2021
Publisher
Springer International Publishing
Published in
Journal of Nuclear Cardiology / Issue 2/2021
Print ISSN: 1071-3581
Electronic ISSN: 1532-6551
DOI
https://doi.org/10.1007/s12350-021-02580-3

Other articles of this Issue 2/2021

Journal of Nuclear Cardiology 2/2021 Go to the issue